| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 10243-44-4 | Isoquino[2,1-d]-1,4-benzodiazepin-2(3H)-one,1,5,6,10b-tetrahydro-1-methyl-12-(trifluoromethyl)-; Isoquino[2,1-d][1,4]benzodiazepin-6(7H)-one,5,9,10,14b-tetrahydro-5-methyl-2-(trifluoromethyl)- (7CI,8CI) |  | C19H19F3N2O | 詳情 | 供應商 | |
| 134336-98-4 | Oxazolo[4,5-b]pyridin-2(3H)-one,3-[2-[4-[3-(trifluoromethyl)phenyl]-1-piperazinyl]ethyl]-; 3-(2-(4-(3-(trifluoromethyl)phenyl)-1-piperazinyl)ethyl)oxazolo(4,5-b)pyridin-2(3H)-one |  | C19H19F3N4O2 | 詳情 | 供應商 | |
| 118249-08-4 | Piperazine,1-[2-(4-azido-3-iodophenyl)ethyl]-4-[3-(trifluoromethyl)phenyl]-; NSC 628236 |  | C19H19F3IN5 | 詳情 | 供應商 | |
| 898763-42-3 | 4'-(4-METHYLPIPERAZINOMETHYL)-3,4,5-TRIFLUOROBENZOPHENONE |  | C19H19F3N2O | 詳情 | 供應商 | |
| 722456-08-8 | ORG 24598 LITHIUM SALT; ORG 24598 鋰鹽; R-(-)-N-甲基-N-[(3R)-3-苯基-3-[4-(三氟甲基)苯氧基]丙基]甘氨酸? | ORG 24598 LITHIUM SALT; R-(-)-N-METHYL-N-[3-[(4-TRIFLUOROMETHYL)PHENOXY]-3-PHENYL-PROPYL]GLYCINE LITHIUM SALT; ORG 24598 LITHIUM SALT |  | C19H19F3LiNO3 | 詳情 | 供應商 |